Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis

Cytokine

Volumn 62, Issue 2, 2013, Pages 262-271

  Araki, Akemi ^a   Nara, Hidetoshi ^a   Rahman, Mizanur ^a   Onoda, Tadashi ^a   Li, Jun ^a   Juliana, Farha Matin ^a   Jin, Lianjin ^a   Murata, Kazuko ^b   Takeda, Yuji ^a   Asao, Hironobu ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b IWAKI MEISEI UNIVERSITY   (Japan)

Author keywords

DSS induced colitis; IBD; IL 21 isoform

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; ISOPROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; EFFECTOR CELL; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; INTERLEUKIN 21 GENE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; METABOLISM; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876788303     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.006     Document Type: Article

References (37)

1. Maynard C.L., Weaver C.T. Intestinal effector T cells in health and disease. Immunity 2009, 31:389-400.
2. Strober W., Fuss I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011, 140:1756-1767.
3. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
4. Fantini M.C., Monteleone G., MacDonald T.T. New players in the cytokine orchestra of inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:1419-1423.
5. De Nitto D., Sarra M., Pallone F., Monteleone G. Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol 2010, 16:3638-3641.
6. Fina D., Sarra M., Fantini M.C., Rizzo A., Caruso R., Caprioli F., et al. Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 2008, 134:1038-1048.
7. Jauch D., Martin M., Schiechl G., Kesselring R., Schlitt H.J., Geissler E.K., et al. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut 2011, 60:1678-1686.
8. Monteleone G., Monteleone I., Fina D., Vavassori P., Del Vecchio Blanco G., Caruso R., et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn's disease. Gastroenterology 2005, 128:687-694.
9. Yamamoto-Furusho J.K., Miranda-Pérez E., Fonseca-Camarillo G., Sánchez-Muñoz F., Barreto-Zuñiga R., Dominguez-Lopez A. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis. Inflamm Bowel Dis 2010, 16:1090.
10. Caruso R., Fina D., Peluso I., Stolfi C., Fantini M.C., Gioia V., et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3α, by gut epithelial cells. Gastroenterology 2007, 132:166-175.
11. Liu Z., Yang L., Cui Y., Wang X., Guo C., Huang Z., et al. IL-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1133-1144.
12. Festen E.A.M., Goyette P., Scott R., Annese V., Zhernakova A., Lian J., et al. Genetic variants in the region harbouring IL2/IL21 associated to ulcerative colitis. Gut 2009, 58:799-804.
13. Márquez A., Orozco G., Martínez A., Palomino-Morales R., Fernández-Arquero M., Mendoza J.L., et al. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol 2009, 104:1968-1975.
14. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
15. Harada M., Magara-Koyanagi K., Watarai H., Nagata Y., Ishii Y., Kojo S., et al. IL-21-induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses. J Exp Med 2006, 203:2929-2937.
16. Rahman M., Nara H., Onoda T., Araki A., Li J., Hoshino T., et al. Cloning and characterization of an isoform of interleukin-21. FEBS Lett 2007, 581:4001-4009.
17. Ozaki K., Spolski R., Ettinger R., Kim H.-P., Wang G., Qi C.-F., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004, 173:5361-5371.
18. Garvin A.M., Abraham K.M., Forbush K.A., Farr A.G., Davison B.L., Perlmutter R.M. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immunol 1990, 2:173-180.
19. H17 cells occurs in the small intestine. Nature 2011, 475:514-518.
20. Asao H., Fu X.Y. Interferon-γ has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem 2000, 275:867-874.
21. Murata K., Ishii N., Takano H., Miura S., Ndhlovu L.C., Nose M., et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 2000, 191:365-374.
22. + memory T cell accumulation. Eur J Immunol 2007, 37:3069-3077.
23. Huang L., Soldevila G., Leeker M., Flavell R., Crispe I.N. The liver Eliminates T cells undergoing antien-triggered apoptosis in vivo. Immunity 1994, 1:741-749.
24. Renno T., Hahne M., Tschopp J., MacDonald H.R. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 1996, 183:431-437.
25. Renno T., Attinger A., Rimoldi D., Hahne M., Tschopp J., MacDonald H.R. Expression of B220 on activated T cell blasts precedes apoptosis. Eur J Immunol 1998, 28:540-547.
26. + T cell expansion and function. J Exp Med 2005, 201:139-148.
27. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
28. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001, 167:6834-6840.
29. Nara H., Rahman M., Araki A., Jin L., Takeda Y., Asao H. IL-21 isoform is a membrane-bound ligand and activates directly interacted cells. Cytokine 2013, 61:656-663.
30. Sasaki S., Ishida Y., Nishio N., Ito S., Isobe K. Thymic involution correlates with severe ulcerative colitis induced by oral administration of dextran sulphate sodium in C57BL/6 mice but not in BALB/c mice. Inflammation 2008, 31:319-328.
31. van Wijk F., Cheroutre H. Intestinal T cells: Facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009, 21:130-138.
32. + intestinal intraepithelial lymphocytes by TGF-β. Nature Immunol 2011, 12:312-319.
33. Poussier P., Ning T., Banerjee D., Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med 2002, 195:1491-1497.
34. Yoshioka Y., Akiyama H., Nakano M., Shoji T., Kanda T., Ohtake Y., et al. Orally administered apple procyanidins protect against experimental inflammatory bowel disease in mice. Int Immunopharmacol 2008, 8:1802-1807.
35. Wurster A.L., Rodgers V.L., Satoskar A.R., Whitters M.J., Young D.A., Collins M., et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naïve Th cells into interferon γ-producing Th1 cells. J Exp Med 2002, 196:969-977.
36. + regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010, 30:80-89.
37. Stolfi C., Rizzo A., Franzè E., Rotondi A., Fantini M.C., Sarra M., et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 2011, 208:2279-2290.